A. H. Thorne

Epidermal Growth Factor Receptor Extracellular Domain Mutations in Glioblastoma Present Opportunities for Clinical Imaging and Therapeutic Development.

Christos Davatzikos, Spyridon Bakas, Michel Bilello, 2018, Cancer cell.

Glioblastoma cellular cross-talk converges on NF-κB to attenuate EGFR inhibitor sensitivity

K. Frazer, P. Mischel, V. Verkhusha, 2017, Genes & development.

Epidermal growth factor receptor targeting and challenges in glioblastoma.

F. Furnari, C. Zanca, A. H. Thorne, 2016, Neuro-oncology.

Alternative RNA Splicing in the Pathogenesis of GBM

W. Cavenee, F. Furnari, A. Thorne, 2015 .

A urokinase receptor-Bim signaling axis emerges during EGFR inhibitor resistance in mutant EGFR glioblastoma.

S. Vandenberg, P. Mischel, W. Cavenee, 2015, Cancer research.

Oncogenic mutations at the EGFR ectodomain structurally converge to remove a steric hindrance on a kinase-coupled cryptic epitope

M. Orozco, A. Scott, E. Lindahl, 2019, Proceedings of the National Academy of Sciences.

Neuroprotective Effect of Ligustilide through Induction of α-Secretase Processing of Both APP and Klotho in a Mouse Model of Alzheimer’s Disease

Hong-jing Zhou, Jun-Rong Du, X. Kuang, 2017, Front. Aging Neurosci..

Adjuvant Screen Identifies Synthetic DNA-Encoding Flt3L and CD80 Immunotherapeutics as Candidates for Enhancing Anti-tumor T Cell Responses

Tricia T. Nguyen, Jian Yan, Neil Cooch, 2020, Frontiers in Immunology.

Role of cysteine-rich 61 protein (CCN1) in macrophage-mediated oncolytic herpes simplex virus clearance.

M. Caligiuri, J. Rich, V. Puduvalli, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

SapC-DOPS-induced lysosomal cell death synergizes with TMZ in glioblastoma

Erwin G. Van Meir, A. Chakravarti, B. Kaur, 2014, Oncotarget.